![Image of hexagons overlapping in different sizes](/images/default-source/siteimages/digitellbackground_generic2_1280x400.png?Status=Master&sfvrsn=e443792c_3)
Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products
![Image with text 'CMC Strategy Forum Japan Advancing Biopharmaceutical Development'](https://www.casss.org/images/default-source/cmc-japan/2023/cmcj2023_120x120_landing.jpg?sfvrsn=f8332483_12)
Speaker Presentation: CMC Strategy Forum Japan 2024
Markovic Ingrid, CBER, FDA, 2024 [Session IV]
Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products